Inactive Instrument

News TherapeuticsMD Inc Nyse

Equities

US88338N1072

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

TherapeuticsMD Announces Full Year 2023 Financial Results	Apr. 01	AQ
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
TherapeuticsMD Announces Full Year 2023 Financial Results	Mar. 29	BU
Knight Therapeutics Announces Launch of Bijuva in Canada	Feb. 06	MT
Knight Therapeutics Announces Product Launch For IMVEXXY In Canada	Jan. 04	MT
North American Morning Briefing : Stocks Seen Building on CPI Rally; PPI Data Due	Nov. 15	DJ
TherapeuticsMD: Q3 Earnings Snapshot	Nov. 15	AQ
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
TherapeuticsMD Announces Third Quarter 2023 Financial Results	Nov. 14	BU
TherapeuticsMD, Inc. Announces Evaluation of Strategic Alternatives	Nov. 13	CI
TherapeuticsMD, Inc. Announces Executive Changes	23-08-18	CI
TherapeuticsMD: Q2 Earnings Snapshot	23-08-14	AQ
TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
TherapeuticsMD Announces Second Quarter 2023 Financial Results	23-08-14	BU
North American Morning Briefing : Stock Futures -2-	23-08-14	DJ
TherapeuticsMD : Change in Certifying Accountants - Form 8-K	23-07-10	PU
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell 3000E Growth Index	23-06-23	CI
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell Microcap Index	23-06-23	CI
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell Microcap Value Index	23-06-23	CI
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell 3000E Value Index	23-06-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News TherapeuticsMD Inc Nyse

Equities

US88338N1072

Summary

Filters